Come up with a name for your new list and we'll add to it:
AC Immune raised a round of funding on January 09, 2014. Investors include
dievini Hopp BioTech Holding & Co..
AC Immune is a clinical stage Swiss-based biopharmaceutical company focused on neurodegenerative diseases with three product candidates in clinical trials. The Company designs, discovers and develops …